The primary purpose of this study is to evaluate safety and effectiveness of the Tricuspid Valve Repair System (TVRS) for treating symptomatic moderate or greater tricuspid regurgitation (TR) in patients currently on medical management and who are deemed appropriate for percutaneous transcatheter intervention. This is a prospective, single arm, multi-center study.
CRITERIA LIST/ QUALIFICATIONS:
Subjects with moderate TR.
Symptom status: NYHA II, III or IV
No indication for left-sided or pulmonary valve correction